{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:40:28Z","timestamp":1792219228349,"version":"4.4.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To evaluate MRI-defined parametrial venous invasion (mrPMVI) for detecting pathological parametrial venous invasion (pPMVI) and its associations with pretreatment lymph node metastasis (LNM) and survival outcomes in locally advanced cervical cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This retrospective study included 42 patients with cervical cancer with parametrial invasion on MRI or histopathology, corresponding to International Federation of Gynecology and Obstetrics 2018 stage IIB or higher disease. Fifteen patients underwent surgery without preoperative therapy and were included in the pathological validation analysis. Image interpretation was primarily based on T2-weighted and diffusion-weighted imaging. Two radiologists independently assessed mrPMVI using a five-point scoring system. Scores\u2009\u2265\u20093 were predefined as mrPMVI-positive. Diagnostic performance for pPMVI and interobserver agreement were evaluated. Univariable logistic and Cox regression analyses were performed for pretreatment LNM and survival outcomes, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      pPMVI was present in 10 of 15 patients. The five-point mrPMVI score showed an area under the receiver operating characteristic curve of 0.87 (95% confidence interval [CI], 0.60\u20130.98) for detecting pPMVI. The predefined threshold (\u2265\u20093) yielded 30.0% sensitivity and 100% specificity. Interobserver agreement for the five-point mrPMVI score was substantial (linearly weighted \u03ba\u2009=\u20090.75). mrPMVI positivity was associated with pretreatment LNM (odds ratio\u2009=\u20094.00, 95% CI: 1.05\u201315.26,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.042). During a median follow-up of 24.0 months, 16 patients experienced disease progression and 10 died. mrPMVI positivity was associated with shorter progression-free survival (hazard ratio\u2009=\u200934.25, 95% CI: 4.35\u2013269.91;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and overall survival (hazard ratio\u2009=\u200910.16; 95% CI: 1.28\u201380.61,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.028).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The mrPMVI score showed potential for identifying pPMVI, although the predefined threshold was highly specific but insensitive. mrPMVI positivity was associated with pretreatment LNM and survival outcomes, suggesting potential complementary value for risk characterization in locally advanced cervical cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11604-026-02099-y","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:43:39Z","timestamp":1792215819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MRI-defined parametrial venous invasion in locally advanced cervical cancer: association with pathological venous invasion, pretreatment lymph node metastasis, and survival outcomes"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6331-8796","authenticated-orcid":false,"given":"Fumitaka","family":"Ejima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arata","family":"Oose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Kanzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Satake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Takumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohisa","family":"Kamimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Yanazume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikumi","family":"Kitazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yoshiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"key":"2099_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"2099_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ijgo.13865","volume":"155","author":"N Bhatla","year":"2021","unstructured":"Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. Int J Gynecol Obstet. 2021;155:28\u201344.","journal-title":"Int J Gynecol Obstet"},{"key":"2099_CR3","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.3802\/jgo.2023.34.e46","volume":"34","author":"H Chang","year":"2023","unstructured":"Chang H, Wang M, Liu Y, Wu Y. Parametrial involvement and decreased survival of women with FIGO stage IIIC1 cervical cancer. J Gynecol Oncol. 2023;34:e46.","journal-title":"J Gynecol Oncol"},{"key":"2099_CR4","doi-asserted-by":"publisher","first-page":"12020","DOI":"10.1038\/s41598-023-39014-8","volume":"13","author":"S Shigeta","year":"2023","unstructured":"Shigeta S, Shimada M, Tsuji K, Watanabe Z, Tanase Y, Matsuo K, et al. Surgically treated cervical cancer in a high-risk group in the era of the 2018 FIGO staging schema: a nationwide study. Sci Rep. 2023;13:12020.","journal-title":"Sci Rep"},{"key":"2099_CR5","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1200\/JCO.2017.75.9985","volume":"36","author":"S Gupta","year":"2018","unstructured":"Gupta S, Maheshwari A, Parab P, Mahantshetty U, Hawaldar R, Sastri Chopra S, et al. Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: a randomized controlled trial. J Clin Oncol. 2018;36:1548\u201355.","journal-title":"J Clin Oncol"},{"key":"2099_CR6","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1200\/JCO.22.02852","volume":"41","author":"GG Kenter","year":"2023","unstructured":"Kenter GG, Greggi S, Vergote I, Katsaros D, Kobierski J, van Doorn H, et al. Randomized phase III study comparing neoadjuvant chemotherapy followed by surgery versus chemoradiation in stage IB2-IIB cervical cancer: EORTC-55994. J Clin Oncol. 2023;41:5035\u201343.","journal-title":"J Clin Oncol"},{"key":"2099_CR7","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.3802\/jgo.2024.35.e15","volume":"35","author":"M Seino","year":"2024","unstructured":"Seino M, Nagase S, Tokunaga H, Yamagami W, Kobayashi Y, Tabata T, et al. Japan society of gynecologic oncology 2022 guidelines for uterine cervical neoplasm treatment. J Gynecol Oncol. 2024;35:e15.","journal-title":"J Gynecol Oncol"},{"key":"2099_CR8","doi-asserted-by":"publisher","first-page":"7802","DOI":"10.1007\/s00330-020-07632-9","volume":"31","author":"L Manganaro","year":"2021","unstructured":"Manganaro L, Lakhman Y, Bharwani N, Gui B, Gigli S, Vinci V, et al. Staging, recurrence and follow-up of uterine cervical cancer using MRI: updated guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018. Eur Radiol. 2021;31:7802\u201316.","journal-title":"Eur Radiol"},{"key":"2099_CR9","doi-asserted-by":"publisher","first-page":"5560","DOI":"10.1007\/s00330-020-06909-3","volume":"30","author":"S Woo","year":"2020","unstructured":"Woo S, Atun R, Ward ZJ, Scott AM, Hricak H, Vargas HA. Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: systematic review and meta-analysis. Eur Radiol. 2020;30:5560\u201377.","journal-title":"Eur Radiol"},{"key":"2099_CR10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s00330-017-4958-x","volume":"28","author":"S Woo","year":"2018","unstructured":"Woo S, Suh CH, Kim SY, Cho JY, Kim SH. Magnetic resonance imaging for detection of parametrial invasion in cervical cancer: an updated systematic review and meta-analysis of the literature between 2012 and 2016. Eur Radiol. 2018;28:530\u201341.","journal-title":"Eur Radiol"},{"key":"2099_CR11","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1007\/s00330-023-10443-3","volume":"34","author":"L Russo","year":"2024","unstructured":"Russo L, Pasciuto T, Lupinelli M, Urbano A, D\u2019Erme L, Amerighi A, et al. The value of MRI in quantification of parametrial invasion and association with prognosis in locally advanced cervical cancer: the PLACE study. Eur Radiol. 2024;34:4003\u201313.","journal-title":"Eur Radiol"},{"key":"2099_CR12","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1148\/radiol.2018172889","volume":"289","author":"X-Y Zhang","year":"2018","unstructured":"Zhang X-Y, Wang S, Li X-T, Wang Y-P, Shi Y-J, Wang L, et al. MRI of extramural venous invasion in locally advanced rectal cancer: relationship to tumor recurrence and overall survival. Radiology. 2018;289:677\u201385.","journal-title":"Radiology"},{"key":"2099_CR13","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2214\/AJR.15.15568","volume":"206","author":"KS Jhaveri","year":"2016","unstructured":"Jhaveri KS, Hosseini-Nik H, Thipphavong S, Assarzadegan N, Menezes RJ, Kennedy ED, et al. MRI detection of extramural venous invasion in rectal cancer: correlation with histopathology using elastin stain. AJR Am J Roentgenol. 2016;206:747\u201355.","journal-title":"AJR Am J Roentgenol"},{"key":"2099_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.5152\/dir.2015.15282","volume":"22","author":"AL Valentini","year":"2016","unstructured":"Valentini AL, Gui B, Micc\u00f2 M, Giuliani M, Rodolfino E, Ninivaggi V, et al. MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer. Diagn Interv Radiol. 2016;22:319\u201325.","journal-title":"Diagn Interv Radiol"},{"key":"2099_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13244-022-01348-8","volume":"14","author":"N Bogveradze","year":"2023","unstructured":"Bogveradze N, Snaebjornsson P, Grotenhuis BA, van Triest B, Lahaye MJ, Maas M, et al. MRI anatomy of the rectum: key concepts important for rectal cancer staging and treatment planning. Insights Imaging. 2023;14:13.","journal-title":"Insights Imaging"},{"key":"2099_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/0090-8258(89)90524-6","volume":"33","author":"CW Drescher","year":"1989","unstructured":"Drescher CW, Hopkins MP, Roberts JA. Comparison of the pattern of metastatic spread of squamous cell cancer and adenocarcinoma of the uterine cervix. Gynecol Oncol. 1989;33:340\u20133.","journal-title":"Gynecol Oncol"},{"key":"2099_CR17","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/cancers16040775","volume":"16","author":"D Fischerova","year":"2024","unstructured":"Fischerova D, Fr\u00fchauf F, Burgetova A, Haldorsen IS, Gatti E, Cibula D. The role of imaging in cervical cancer staging: ESGO\/ESTRO\/ESP guidelines (update 2023). Cancers (Basel). 2024;16:775.","journal-title":"Cancers (Basel)"},{"key":"2099_CR18","unstructured":"Loughrey M, Quirke P, Shepherd N. Dataset for histopathological reporting of colorectal cancer, 5th ed. The Royal College of Pathologists Website. Published 2023. https:\/\/www.rcpath.org\/resourceLibrary\/g049-dataset-for-histopathological-reporting-of-colorectal-cancer.html"},{"key":"2099_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32\u20135.","journal-title":"Cancer"},{"key":"2099_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life-tables. J R Stat Soc Ser B. 1972;34:187\u2013202.","journal-title":"J R Stat Soc Ser B"},{"key":"2099_CR21","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00404-019-05341-3","volume":"300","author":"P Widschwendter","year":"2019","unstructured":"Widschwendter P, Janni W, Scholz C, De Gregorio A, De Gregorio N, Friedl TWP. Prognostic factors for and pattern of lymph-node involvement in patients with operable cervical cancer. Arch Gynecol Obstet. 2019;300:1709\u201318.","journal-title":"Arch Gynecol Obstet"},{"key":"2099_CR22","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1245\/s10434-023-13225-9","volume":"30","author":"HM Thompson","year":"2023","unstructured":"Thompson HM, Bates DDB, Pernicka JG, Park SJ, Nourbakhsh M, Fuqua JL 3rd, et al. MRI assessment of extramural venous invasion before and after total neoadjuvant therapy for locally advanced rectal cancer and its association with disease-free and overall survival. Ann Surg Oncol. 2023;30:3957\u201365.","journal-title":"Ann Surg Oncol"},{"key":"2099_CR23","doi-asserted-by":"publisher","first-page":"20523","DOI":"10.1002\/cam4.6625","volume":"12","author":"M Chen","year":"2023","unstructured":"Chen M, Ma Y, Song Y-W, Huang J, Gao Y-H, Zheng J, et al. Survival outcomes of different neoadjuvant treatment regimens in patients with locally advanced rectal cancer and MRI-detected extramural venous invasion. Cancer Med. 2023;12:20523\u201337.","journal-title":"Cancer Med"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-026-02099-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-026-02099-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-026-02099-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:43:40Z","timestamp":1792215820000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-026-02099-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":23,"alternative-id":["2099"],"URL":"https:\/\/doi.org\/10.1007\/s11604-026-02099-y","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"20 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the appropriate institutional ethics committee (approval no. 250096epi). The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for informed consent was waived by the Institutional Review Board because of the retrospective nature of the study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}